Penson DF - Search Results

1

Why do men choose one treatment over another?: a review of patient decision making for localized prostate cancer.

Zeliadt SB, Ramsey SD, Penson DF, Hall IJ, Ekwueme DU, Stroud L, Lee JW. Zeliadt SB, et al. Among authors: penson df. Cancer. 2006 May 1;106(9):1865-74. doi: 10.1002/cncr.21822. Cancer. 2006. PMID: 16568450 Free article.

2

Treatment outcomes in localized prostate cancer: a patient-oriented approach.

Lee R, Penson DF. Lee R, et al. Among authors: penson df. Semin Urol Oncol. 2002 Feb;20(1):63-73. doi: 10.1053/suro.2002.30400. Semin Urol Oncol. 2002. PMID: 11828359 Review.

3

Quality of life following prostate cancer treatments.

Penson DF. Penson DF. Curr Urol Rep. 2000 May;1(1):71-7. doi: 10.1007/s11934-000-0038-9. Curr Urol Rep. 2000. PMID: 12084344 Review.

4

Overdiagnosis due to prostate-specific antigen screening: lessons from U.S. prostate cancer incidence trends.

Etzioni R, Penson DF, Legler JM, di Tommaso D, Boer R, Gann PH, Feuer EJ. Etzioni R, et al. Among authors: penson df. J Natl Cancer Inst. 2002 Jul 3;94(13):981-90. doi: 10.1093/jnci/94.13.981. J Natl Cancer Inst. 2002. PMID: 12096083

5

Cigarette smoking and risk of prostate cancer in middle-aged men.

Plaskon LA, Penson DF, Vaughan TL, Stanford JL. Plaskon LA, et al. Among authors: penson df. Cancer Epidemiol Biomarkers Prev. 2003 Jul;12(7):604-9. Cancer Epidemiol Biomarkers Prev. 2003. PMID: 12869398

6

Race independently predicts prostate specific antigen testing frequency following a prostate carcinoma diagnosis.

Zeliadt SB, Penson DF, Albertsen PC, Concato J, Etzioni RD. Zeliadt SB, et al. Among authors: penson df. Cancer. 2003 Aug 1;98(3):496-503. doi: 10.1002/cncr.11492. Cancer. 2003. PMID: 12879465 Free article.

7

Five-year outcomes after prostatectomy or radiotherapy for prostate cancer: the prostate cancer outcomes study.

Potosky AL, Davis WW, Hoffman RM, Stanford JL, Stephenson RA, Penson DF, Harlan LC. Potosky AL, et al. Among authors: penson df. J Natl Cancer Inst. 2004 Sep 15;96(18):1358-67. doi: 10.1093/jnci/djh259. J Natl Cancer Inst. 2004. PMID: 15367568

8

An ecologic study of prostate-specific antigen screening and prostate cancer mortality in nine geographic areas of the United States.

Shaw PA, Etzioni R, Zeliadt SB, Mariotto A, Karnofski K, Penson DF, Weiss NS, Feuer EJ. Shaw PA, et al. Among authors: penson df. Am J Epidemiol. 2004 Dec 1;160(11):1059-69. doi: 10.1093/aje/kwh336. Am J Epidemiol. 2004. PMID: 15561985

9

Racial disparity in primary and adjuvant treatment for nonmetastatic prostate cancer: SEER-Medicare trends 1991 to 1999.

Zeliadt SB, Potosky AL, Etzioni R, Ramsey SD, Penson DF. Zeliadt SB, et al. Among authors: penson df. Urology. 2004 Dec;64(6):1171-6. doi: 10.1016/j.urology.2004.07.037. Urology. 2004. PMID: 15596192

10

The cost-effectiveness of combined androgen blockade with bicalutamide and luteinizing hormone releasing hormone agonist in men with metastatic prostate cancer.

Penson DF, Ramsey S, Veenstra D, Clarke L, Gandhi S, Hirsch M. Penson DF, et al. J Urol. 2005 Aug;174(2):547-52; discussion 552. doi: 10.1097/01.ju.0000165569.48372.4c. J Urol. 2005. PMID: 16006889

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

622 results

Search Page

Filters